MSFT 437.49 1.4587% AAPL 242.99 0.1401% NVDA 145.11 3.4579% GOOGL 174.36 1.7626% GOOG 176.05 1.7512% AMZN 218.21 2.2348% META 613.54 -0.0179% AVGO 170.365 1.3173% TSLA 357.75 1.8013% TSM 200.69 0.905% LLY 833.585 2.4904% V 310.57 -0.7795% JPM 243.555 -0.5167% UNH 610.73 0.9087% NVO 109.26 0.0549% WMT 94.295 0.8395% LVMUY 127.2 -0.9269% XOM 114.29 -2.8724% LVMHF 638.8 -0.6084% MA 521.685 -0.8543%

Eli Lilly and Company

Healthcare US LLY

833.585USD
20.25(2.49%)

Last update at 2024-12-04T20:55:00Z

Day Range

820.50846.46
LowHigh

52 Week Range

307.17628.81
LowHigh

Fundamentals

  • Previous Close 813.33
  • Market Cap541475.24M
  • Volume3162028
  • P/E Ratio103.14
  • Dividend Yield0.91%
  • EBITDA11316.30M
  • Revenue TTM32072.50M
  • Revenue Per Share TTM35.62
  • Gross Profit TTM 21911.60M
  • Diluted EPS TTM5.53

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 6806.40M 6155.50M 7229.90M 5265.90M 3680.10M
Minority interest - - 183.60M 92.20M 1080.40M
Net income 6244.80M 5581.70M 6193.70M 4637.90M 3232.00M
Selling general administrative 6440.40M 6431.60M 6121.20M 6213.80M 5975.10M
Selling and marketing expenses - - - 6213.80M 5975.10M
Gross profit 21911.60M 21005.60M 19056.50M 17598.30M 16811.60M
Reconciled depreciation 1522.50M 1547.60M 1323.90M 1232.60M 1609.00M
Ebit 7127.30M 6357.10M 6058.00M 4974.30M 8036.10M
Ebitda 9433.50M 8739.10M 7641.20M 6604.70M 9645.10M
Depreciation and amortization 2306.20M 2382.00M 1583.20M 1630.40M 1609.00M
Non operating income net other -320.90000M - - 291.60M 74.80M
Operating income 7127.30M 6357.10M 6058.00M 4974.30M 6186.80M
Other operating expenses 20261.00M 20770.30M 17690.20M 16530.00M 15708.00M
Interest expense 331.60M 339.80M 359.60M 400.60M 272.10M
Tax provision 561.60M 573.80M 1036.20M 628.00M 563.70M
Interest income 268.80M 314.40M 326.60M 80.40M 161.30M
Net interest income -268.80000M -314.40000M -326.60000M -320.20000M -110.80000M
Extraordinary items - 0.00000M 0.00000M 3680.50M -93.90000M
Non recurring 244.60M - - 815.20M 2465.90M
Other items - - - - -
Income tax expense 561.60M 573.80M 1036.20M 628.00M 529.50M
Total revenue 28541.40M 28318.40M 24539.80M 22319.50M 21493.30M
Total operating expenses 13631.20M 13457.50M 12206.90M 11808.80M 11026.30M
Cost of revenue 6629.80M 7312.80M 5483.30M 4721.20M 4681.70M
Total other income expense net -320.90000M -201.60000M 1171.90M 291.60M -2105.20000M
Discontinued operations - - - 3680.50M 81.40M
Net income from continuing ops 6244.80M 5581.70M 6193.70M 4637.90M 3232.00M
Net income applicable to common shares 6244.80M 5581.70M 6193.70M 8318.40M 3232.00M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 49489.80M 48806.00M 46633.10M 39286.10M 43908.40M
Intangible assets 7206.60M 7691.90M 7450.00M 6618.00M 1068.00M
Earning assets - - - - -
Other current assets 2954.10M 2530.60M 2871.50M 2538.90M 2146.50M
Total liab 38714.40M 39651.20M 40807.90M 36587.00M 32999.30M
Total stockholder equity 10649.80M 8979.20M 5641.60M 2606.90M 9828.70M